267 related articles for article (PubMed ID: 26347257)
1. Spray-dried powders enhance vaginal siRNA delivery by potentially modulating the mucus molecular sieve structure.
Wu N; Zhang X; Li F; Zhang T; Gan Y; Li J
Int J Nanomedicine; 2015; 10():5383-96. PubMed ID: 26347257
[TBL] [Abstract][Full Text] [Related]
2. Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery.
Zimmermann CM; Baldassi D; Chan K; Adams NBP; Neumann A; Porras-Gonzalez DL; Wei X; Kneidinger N; Stoleriu MG; Burgstaller G; Witzigmann D; Luciani P; Merkel OM
J Control Release; 2022 Nov; 351():137-150. PubMed ID: 36126785
[TBL] [Abstract][Full Text] [Related]
3. Freeze-dried mucoadhesive polymeric system containing pegylated lipoplexes: Towards a vaginal sustained released system for siRNA.
Furst T; Dakwar GR; Zagato E; Lechanteur A; Remaut K; Evrard B; Braeckmans K; Piel G
J Control Release; 2016 Aug; 236():68-78. PubMed ID: 27329774
[TBL] [Abstract][Full Text] [Related]
4. Aerosol delivery of nanoparticles in uniform mannitol carriers formulated by ultrasonic spray freeze drying.
D'Addio SM; Chan JG; Kwok PC; Benson BR; Prud'homme RK; Chan HK
Pharm Res; 2013 Nov; 30(11):2891-901. PubMed ID: 23893019
[TBL] [Abstract][Full Text] [Related]
5. Identification of Factors of Importance for Spray Drying of Small Interfering RNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles for Inhalation.
Dormenval C; Lokras A; Cano-Garcia G; Wadhwa A; Thanki K; Rose F; Thakur A; Franzyk H; Foged C
Pharm Res; 2019 Aug; 36(10):142. PubMed ID: 31376020
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment of human cervicovaginal mucus with pluronic F127 enhances nanoparticle penetration without compromising mucus barrier properties to herpes simplex virus.
Ensign LM; Lai SK; Wang YY; Yang M; Mert O; Hanes J; Cone R
Biomacromolecules; 2014 Dec; 15(12):4403-9. PubMed ID: 25347518
[TBL] [Abstract][Full Text] [Related]
7. Inhalable siRNA-loaded nano-embedded microparticles engineered using microfluidics and spray drying.
Agnoletti M; Bohr A; Thanki K; Wan F; Zeng X; Boetker JP; Yang M; Foged C
Eur J Pharm Biopharm; 2017 Nov; 120():9-21. PubMed ID: 28780275
[TBL] [Abstract][Full Text] [Related]
8. Effect of thermal and shear stresses in the spray drying process on the stability of siRNA dry powders.
Wu J; Wu L; Wan F; Rantanen J; Cun D; Yang M
Int J Pharm; 2019 Jul; 566():32-39. PubMed ID: 31077763
[TBL] [Abstract][Full Text] [Related]
9. Inhalable dry powder formulations of siRNA and pH-responsive peptides with antiviral activity against H1N1 influenza virus.
Liang W; Chow MY; Lau PN; Zhou QT; Kwok PC; Leung GP; Mason AJ; Chan HK; Poon LL; Lam JK
Mol Pharm; 2015 Mar; 12(3):910-21. PubMed ID: 25599953
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of spray-dried inhalable powders containing nanoaggregates for pulmonary delivery of anti-tubercular drugs.
Kaur R; Garg T; Das Gupta U; Gupta P; Rath G; Goyal AK
Artif Cells Nanomed Biotechnol; 2016; 44(1):182-7. PubMed ID: 24992699
[TBL] [Abstract][Full Text] [Related]
11. Development and in vitro/in vivo evaluation of HPMC/chitosan gel containing simvastatin loaded self-assembled nanomicelles as a potent wound healing agent.
Varshosaz J; Taymouri S; Minaiyan M; Rastegarnasab F; Baradaran A
Drug Dev Ind Pharm; 2018 Feb; 44(2):276-288. PubMed ID: 29043860
[TBL] [Abstract][Full Text] [Related]
12. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
Li X; Vogt FG; Hayes D; Mansour HM
J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
[TBL] [Abstract][Full Text] [Related]
13. Preparation of honokiol-loaded chitosan microparticles via spray-drying method intended for pulmonary delivery.
Li X; Guo Q; Zheng X; Kong X; Shi S; Chen L; Zhao X; Wei Y; Qian Z
Drug Deliv; 2009 Apr; 16(3):160-6. PubMed ID: 19514976
[TBL] [Abstract][Full Text] [Related]
14. Conception, preparation and properties of functional carrier particles for pulmonary drug delivery.
Odziomek M; Sosnowski TR; GradoĊ L
Int J Pharm; 2012 Aug; 433(1-2):51-9. PubMed ID: 22580211
[TBL] [Abstract][Full Text] [Related]
15. Optimization and dissolution performance of spray-dried naproxen nano-crystals.
Kumar S; Shen J; Zolnik B; Sadrieh N; Burgess DJ
Int J Pharm; 2015; 486(1-2):159-66. PubMed ID: 25814034
[TBL] [Abstract][Full Text] [Related]
16. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.
Jensen DK; Jensen LB; Koocheki S; Bengtson L; Cun D; Nielsen HM; Foged C
J Control Release; 2012 Jan; 157(1):141-8. PubMed ID: 21864597
[TBL] [Abstract][Full Text] [Related]
17. Development of Sustained Release Oseltamivir Phosphate Dry Powder Inhaler:
Sahastrabudhe H; Kenjale P; Pokharkar V
Curr Drug Deliv; 2020; 17(8):703-710. PubMed ID: 32472998
[TBL] [Abstract][Full Text] [Related]
18. Budesonide dry powder for inhalation: effects of leucine and mannitol on the efficiency of delivery.
Rattanupatam T; Srichana T
Drug Deliv; 2014 Sep; 21(6):397-405. PubMed ID: 24401124
[TBL] [Abstract][Full Text] [Related]
19. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
Cheow WS; Ng ML; Kho K; Hadinoto K
Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560
[TBL] [Abstract][Full Text] [Related]
20. Inhaled powder formulation of naked siRNA using spray drying technology with l-leucine as dispersion enhancer.
Chow MYT; Qiu Y; Lo FFK; Lin HHS; Chan HK; Kwok PCL; Lam JKW
Int J Pharm; 2017 Sep; 530(1-2):40-52. PubMed ID: 28720537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
